IBI128

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI128, covering 2025-03-27 to 2025-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects [Phase 2]